Mutant in combination with Df(2R)vg-C, Df(2R)CX1 or Df(2R)vg-D produce defects in wing veins L2, L4 and L5.
E(Egfr)B56B56 is an enhancer of visible phenotype of Egfrt1
E(Egfr)B56[+]/E(Egfr)B56B56 is a suppressor of visible | dominant phenotype of Snr1E1
E(Egfr)B56B56 is a suppressor of visible phenotype of N55e11
E(Egfr)B56B56 is a suppressor of visible phenotype of Su(H)16
E(Egfr)B56B56, vnC221 has visible phenotype
Df(2R)Egfr18, E(Egfr)B56B56 has visible phenotype
E(Egfr)B56B56 is an enhancer of wing vein L2 phenotype of Egfrt1
E(Egfr)B56B56 is an enhancer of wing vein L4 phenotype of Egfrt1
E(Egfr)B56B56 is an enhancer of wing vein L5 phenotype of Egfrt1
E(Egfr)B56[+]/E(Egfr)B56B56 is a suppressor of wing vein | ectopic phenotype of Snr1E1
E(Egfr)B56B56 is a suppressor of wing phenotype of N55e11
E(Egfr)B56B56 is a suppressor of wing phenotype of Su(H)16
E(Egfr)B56B56, vnC221 has wing vein L2 phenotype
E(Egfr)B56B56, vnC221 has wing vein L5 phenotype
E(Egfr)B56B56, vnC221 has wing vein L4 phenotype
Df(2R)Egfr18, E(Egfr)B56B56 has wing vein L4 phenotype